TransMedics Group (TMDX) Tops Q4 EPS by 2c, Revenues Beat
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/22/2026
- Wall St futures pause after AI rally, focus on Mideast tensions
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Oil price dips to $100 on hopes of US-Iran diplomacy, partial recovery in Saudi exports
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- Investors may be underpricing how far rate hikes could go, Deutsche says
- Pennsylvania measles cases near 800 as outbreak grows
- A timeline of Trump administration moves to weaken endangered species protections
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
Pre-Open Stock Movers 03/02: (INUV) (TMDX) (RKT) Higher; (FGEN) (LODE) (AI) Lower (more...)
March 2, 2021 9:28 AM ESTToday's Pre-Open Stock Movers
Inuvo (NYSE: INUV) 24% HIGHER; On February 24, 2021, Vertro, Inc., a wholly-owned subsidiary of Inuvo, Inc. entered into a Google Services Agreement with Google LLC, effective as of March 1, 2021.
TransMedics Group (TMDX) PT Raised to $40 at Oppenheimer
March 2, 2021 6:14 AM ESTOppenheimer analyst Suraj Kalia raised the price target on TransMedics Group (NASDAQ: TMDX) to $40.00 (from $25.00) while maintaining an Outperform rating.
The analyst commented, "After close (3/1), TransMedics announced FDA has communicated its intent to hold a Circulatory Systems Device Advisory Panel meeting on 4/6. While... More
TransMedics Group (TMDX) Announces Scheduling of OCS Heart FDA Advisory Committee Meeting
March 1, 2021 4:17 PM ESTTransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart and liver failure, today announced that the FDA's Office of Health Technology 2 (Cardiovascular Devices) has communicated its intent to hold a Circulatory... More
